TAP2 and cancer: Quantification of the markers within specific cell type compartments revealed higher IL-4 mRNA expression in intratumor myeloid cells than in cancer cells, as well as lower TAP2 protein levels in cases with high myeloid cell IL-4 mRNA expression (Figs. 5L-M).